Mankind Pharma Secures License for Innovative Insulin Therapies from China's Chenan Bio, ETPharma

New Delhi: Mankind Pharma has entered into an exclusive in-licensing agreement with China’s Chongqing Chenan Biopharmaceutical for the commercialisation of two insulin analogues, insulin degludec and insulin degludec + aspart combination, i
Read more...